These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38464040)

  • 1. A tension offloading patch mitigates dermal fibrosis induced by pro-fibrotic skin injections.
    Talbott HE; Griffin MF; Mascharak S; Parker JBL; Kuhnert MM; Guo JL; Diaz Deleon NM; Lavin C; Abbas D; Guardino N; Morgan A; Valencia C; Cotterell A; Longaker MT; Wan DC
    Res Sq; 2024 Mar; ():. PubMed ID: 38464040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined effect of genetic background and gender in a mouse model of bleomycin-induced skin fibrosis.
    Ruzehaji N; Avouac J; Elhai M; Frechet M; Frantz C; Ruiz B; Distler JH; Allanore Y
    Arthritis Res Ther; 2015 May; 17(1):145. PubMed ID: 26025306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelin 1 contributes to the effect of transforming growth factor beta1 on wound repair and skin fibrosis.
    Lagares D; García-Fernández RA; Jiménez CL; Magán-Marchal N; Busnadiego O; Lamas S; Rodríguez-Pascual F
    Arthritis Rheum; 2010 Mar; 62(3):878-89. PubMed ID: 20131241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parabiosis and transplantation models show no evidence of circulating dermal fibroblast progenitors in bleomycin-induced skin fibrosis.
    Boban I; Barisic-Dujmovic T; Clark SH
    J Cell Physiol; 2008 Jan; 214(1):230-7. PubMed ID: 17579342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scleroderma-like Impairment in the Network of Telocytes/CD34
    Rosa I; Romano E; Fioretto BS; Guasti D; Ibba-Manneschi L; Matucci-Cerinic M; Manetti M
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral Hybrid CB
    Zawatsky CN; Park JK; Abdalla J; Kunos G; Iyer MR; Cinar R
    Front Endocrinol (Lausanne); 2021; 12():744857. PubMed ID: 34650521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRPA1 as a potential factor and drug target in scleroderma: dermal fibrosis and alternative macrophage activation are attenuated in TRPA1-deficient mice in bleomycin-induced experimental model of scleroderma.
    Mäki-Opas I; Hämäläinen M; Moilanen E; Scotece M
    Arthritis Res Ther; 2023 Jan; 25(1):12. PubMed ID: 36698198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effect of kaempferol on skin fibrosis in systemic sclerosis by the suppression of oxidative stress.
    Sekiguchi A; Motegi SI; Fujiwara C; Yamazaki S; Inoue Y; Uchiyama A; Akai R; Iwawaki T; Ishikawa O
    J Dermatol Sci; 2019 Oct; 96(1):8-17. PubMed ID: 31447184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stromal cells prevent bleomycin-induced lung and skin fibrosis in aged mice and restore wound healing.
    Rubio GA; Elliot SJ; Wikramanayake TC; Xia X; Pereira-Simon S; Thaller SR; Glinos GD; Jozic I; Hirt P; Pastar I; Tomic-Canic M; Glassberg MK
    J Cell Physiol; 2018 Aug; 233(8):5503-5512. PubMed ID: 29271488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secukinumab and metformin ameliorate dermal fibrosis by decreasing tissue interleukin-17 levels in bleomycin-induced dermal fibrosis.
    Karatas A; Celik C; Oz B; Akar ZA; Etem EO; Dagli AF; Koca SS
    Int J Rheum Dis; 2021 Jun; 24(6):795-802. PubMed ID: 33835703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptide Cortistatin Regulates Dermal and Pulmonary Fibrosis in an Experimental Model of Systemic Sclerosis.
    Barriga M; Benitez R; Robledo G; Caro M; O'Valle F; Campos-Salinas J; Delgado M
    Neuroendocrinology; 2022; 112(8):784-795. PubMed ID: 34649259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diminished induction of skin fibrosis in mice with MCP-1 deficiency.
    Ferreira AM; Takagawa S; Fresco R; Zhu X; Varga J; DiPietro LA
    J Invest Dermatol; 2006 Aug; 126(8):1900-8. PubMed ID: 16691201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCN2 is required for bleomycin-induced skin fibrosis in mice.
    Liu S; Shi-wen X; Abraham DJ; Leask A
    Arthritis Rheum; 2011 Jan; 63(1):239-46. PubMed ID: 20936632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cannabinoid WIN55, 212-2 abrogates dermal fibrosis in scleroderma bleomycin model.
    Balistreri E; Garcia-Gonzalez E; Selvi E; Akhmetshina A; Palumbo K; Lorenzini S; Maggio R; Lucattelli M; Galeazzi M; Distler JW
    Ann Rheum Dis; 2011 Apr; 70(4):695-9. PubMed ID: 21177293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bosentan reverses the pro-fibrotic phenotype of systemic sclerosis dermal fibroblasts via increasing DNA binding ability of transcription factor Fli1.
    Akamata K; Asano Y; Aozasa N; Noda S; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Sato S
    Arthritis Res Ther; 2014 Apr; 16(2):R86. PubMed ID: 24708674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trichostatin A prevents the accumulation of extracellular matrix in a mouse model of bleomycin-induced skin fibrosis.
    Huber LC; Distler JH; Moritz F; Hemmatazad H; Hauser T; Michel BA; Gay RE; Matucci-Cerinic M; Gay S; Distler O; Jüngel A
    Arthritis Rheum; 2007 Aug; 56(8):2755-64. PubMed ID: 17665426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone Morphogenetic Protein-6 Inhibits Fibrogenesis in Scleroderma Offering Treatment Options for Fibrotic Skin Disease.
    Arndt S; Karrer S; Hellerbrand C; Bosserhoff AK
    J Invest Dermatol; 2019 Sep; 139(9):1914-1924.e6. PubMed ID: 30878675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Animal model of sclerotic skin. II. Bleomycin induced scleroderma in genetically mast cell deficient WBB6F1-W/W(V) mice.
    Yamamoto T; Takahashi Y; Takagawa S; Katayama I; Nishioka K
    J Rheumatol; 1999 Dec; 26(12):2628-34. PubMed ID: 10606374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New strategy of modulating incision tension: A wound tension offloading device applied before surgery.
    Zhang S; Nabi O; Jiang X
    Dermatol Ther; 2021 Mar; 34(2):e14797. PubMed ID: 33484082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with abatacept prevents experimental dermal fibrosis and induces regression of established inflammation-driven fibrosis.
    Ponsoye M; Frantz C; Ruzehaji N; Nicco C; Elhai M; Ruiz B; Cauvet A; Pezet S; Brandely ML; Batteux F; Allanore Y; Avouac J
    Ann Rheum Dis; 2016 Dec; 75(12):2142-2149. PubMed ID: 26912566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.